Statements

2025

DEA and HHS Issue Final Telemedicine Rule for Buprenorphine Access - January 17, 2025

2024

DEA and HHS Extend Telemedicine Flexibilities through 2025 - November 15, 2024

2023

SAMHSA Applauds Expansion of Access to Medication for Opioid Use Disorder (MOUD) - January 18, 2023

2021

Joint Statement of Commitment to Continuing Cooperation on the National Judicial Task Force to Examine State Courts’ Response to Mental Illness - July 16, 2021

Statement on 42 CFR Part 2 Amendments Process - April 9, 2021